Table 1.
Characteristics of the patients at baseline.
| Eso-N (n = 33) | Eso (n = 33) | p value | |
|---|---|---|---|
| Age, year | 44.55 ± 9.29 | 46.12 ± 11.14 | 0.535 |
| Female, n (%) | 13 (50) | 10 (37) | 0.438 |
| BMI, kg m−2 | 25.50 ± 2.34 | 26.09 ± 3.62 | 0.438 |
| APACHEII score | 9.76 ± 4.03 | 9.24 ± 2.49 | 0.535 |
| Marshall scores | 2.38 ± 1.12 | 2.21 ± 1.02 | 0.591 |
| Organs involved, n (%) | |||
| Respiratory | 27 (81.81%) | 25 (75.75%) | 0.382 |
| Renal | 5 (15.15%) | 7 (21.21%) | 0.375 |
| Cardiovascular | 1 (3.03%) | 2 (6.06%) | 0.5 |
| CRP , mg/ml | 249.93 ± 114.9 | 254.82 ± 132.79 | 0.873 |
| Feeding tube, n (%) | 11 (33.3) | 8 (24.2) | 0.294 |
| Etiology, n (%) | 0.446 | ||
| Biliary | 20 (60.6) | 15 (45.5) | |
| Alcohol | 2 (6.1) | 4 (12.1) | |
| Others | 2 (6.1) | 5 (15.2) | |
| Uncertain | 9 (27.3) | 9 (27.3) | |
| Antibiotics in early phase, n (%) | 4 (12) | 3 (9) | 0.689 |
| Initiation of enteral nutrition, day | 3.4 ± 1.6 | 3.8 ± 1.8 | 0.344 |
| Mortality | 0 | 0 | – |
BMI body mass index, APACHE II acute physiology and chronic health evaluation, CRP C-reaction protein.